Evidence map›Paper›PMID 30038233›Full record

ArticleMolecular psychiatry2020

Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks.

Santiago G Lago, Jakub Tomasik, Geertje F van Rees, Jordan M Ramsey, Frieder Haenisch, Jason D Cooper, Jantine A Broek, Paula Suarez-Pinilla, Tillmann Ruland, Bonnie Auyeug and 6 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Cross-Disorder Analysis of De Novo Mutations in Neuropsychiatric Disorders.Journal of autism and developmental disorders · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Santiago G Lago *Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-3276-430X
Jakub Tomasik *Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Geertje F van ReesDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-9431-0653
Jordan M RamseyDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Frieder HaenischDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-7961-4467
Jason D CooperDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Jantine A BroekDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Paula Suarez-PinillaDepartment of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain.
Tillmann RulandDepartment of Psychiatry and Psychotherapy, University of Münster, Münster, Germany.
Bonnie AuyeugAutism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.
Olya MikovaFoundation Biological Psychiatry, Sofia, Bulgaria.
Nikolett KabacsCambridgeshire and Peterborough NHS Foundation Trust, Cambridge, UK.
Volker AroltDepartment of Psychiatry and Psychotherapy, University of Münster, Münster, Germany.
Simon Baron-CohenAutism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK.
Benedicto Crespo-FacorroDepartment of Psychiatry, Marqués de Valdecilla University Hospital, IDIVAL, School of Medicine, University of Cantabria, Santander, Spain.
Sabine BahnDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK. sb209@cam.ac.uk.
University of Cambridge · GBUniversidad de Cantabria · ESUniversity of Münster · DEBulgarian Biodiversity Foundation · BGCambridgeshire and Peterborough NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuropsychiatric disorders overlap in symptoms and share genetic risk factors, challenging their current classification into distinct diagnostic categories. Novel cross-disorder approaches are needed to improve our understanding of the heterogeneous nature of neuropsychiatric diseases and overcome existing bottlenecks in their diagnosis and treatment. Here we employ high-content multi-parameter phospho-specific flow cytometry, fluorescent cell barcoding and automated sample preparation to characterize ex vivo signaling network responses (n = 1764) measured at the single-cell level in B and T lymphocytes across patients diagnosed with four major neuropsychiatric disorders: autism spectrum condition (ASC), bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SCZ; n = 25 each), alongside matched healthy controls (n = 100). We identified 25 nodes (individual cell subtype-epitope-ligand combinations) significantly altered relative to the control group, with variable overlap between different neuropsychiatric diseases and heterogeneously expressed at the level of each individual patient. Reconstruction of the diagnostic categories from the altered nodes revealed an overlapping neuropsychiatric spectrum extending from MDD on one end, through BD and SCZ, to ASC on the other end. Network analysis showed that although the pathway structure of the epitopes was broadly preserved across the clinical groups, there were multiple discrete alterations in network connectivity, such as disconnections within the antigen/integrin receptor pathway and increased negative regulation within the Akt1 pathway in CD4

Indexed as

Autism Spectrum DisorderBipolar DisorderMajor Depressive DisorderSchizophreniaSignal TransductionSingle-Cell AnalysisFemaleHumansMale

Identifiers

PMID30038233
OpenAlexW2882981370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.